Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth

Dopamine receptors have been reported to play important roles in cancer progression. However, the role of dopamine receptor D3 (DRD3) in hepatocellular carcinoma (HCC) remains unclear.